UPSIDE Foods is a company.
UPSIDE Foods has raised $580.3M across 5 funding rounds.
Key people at UPSIDE Foods.
UPSIDE Foods has raised $580.3M in total across 5 funding rounds.
Key people at UPSIDE Foods.
UPSIDE Foods has raised $580.3M in total across 5 funding rounds.
UPSIDE Foods's investors include Andreessen Horowitz, Atomico, At One Ventures, FPV Fund, Future Ventures, Innovation Endeavors, Kleiner Perkins, LGF, Mayfield, McWin Capital Partners, Norwest Venture Partners, Sequoia Capital.
UPSIDE Foods is a pioneering food technology company that cultivates real meat directly from animal cells, eliminating the need to raise and slaughter animals. It produces beef, chicken, duck, and seafood products like meatballs, filets, hot dogs, sausages, and fried chicken sandwiches, serving consumers, restaurants, and the food industry while addressing environmental damage, animal welfare issues, and health risks from conventional meat production[1][2][4][5][6]. The company solves the global protein demand problem with a more humane, sustainable alternative that matches taste and texture, backed by strong growth including $608 million raised, unicorn status (over $1B valuation), the first U.S. FDA greenlight for cultivated chicken in 2022, and partnerships with chefs like Dominique Crenn[1][2][5][6].
UPSIDE Foods was founded in 2015 as Memphis Meats by cardiologist Dr. Uma Valeti, inspired by advances in cultivating heart muscle tissue to create a humane, sustainable meat alternative[1][2][3][4][5]. Valeti, a medical doctor, rallied a team to reject conventional farming's inefficiencies, producing the world's first cultivated beef meatball in 2016, followed by chicken and duck in 2017[1][2][8]. Early traction included Series A funding from Bill Gates, Cargill, Kimbal Musk, Richard Branson, and others; Tyson Foods investment in 2018; and co-founding the Alliance for Meat, Poultry, and Seafood Innovation in 2019[1]. Pivotal moments: rebranding to UPSIDE Foods in 2021, opening the EPIC facility, acquiring Cultured Decadence for seafood in 2022, and a $400M Series C for unicorn status[1][5][6].
UPSIDE Foods rides the cellular agriculture trend, leveraging biotech to meet rising global meat demand amid climate change, with meat production contributing heavily to emissions, deforestation, and animal suffering[3][4][6]. Timing aligns with consumer shifts—73% willing to change habits for sustainability—and regulatory progress like FDA approvals, enabling commercialization[2][4][5]. Market forces favoring it include investor enthusiasm (inspiring ~100 competitors), scalable lab processes reducing farming's environmental footprint, and partnerships with giants like Tyson and Cargill[1][3][8]. It influences the ecosystem by co-founding coalitions, acquiring startups, and driving talent development, accelerating industry-wide adoption of cultivated meat[1][6].
UPSIDE Foods is poised for commercialization with FDA-approved chicken nearing restaurant expansion and a diverse portfolio targeting popular items like sandwiches[2][6]. Trends like cost reductions in cell tech, USDA approvals, and sustainability mandates will propel scaling, potentially disrupting the $1T+ meat market. Its influence may evolve from pioneer to category leader, inspiring ethical food innovation while proving cultivated meat's viability—turning "science fiction" into everyday plates, as its journey from 2015 meatball to menu milestone demonstrates[2][6].
UPSIDE Foods has raised $580.3M across 5 funding rounds. Most recently, it raised $400.0M Series C in April 2022.
